Sickle cell disease: Relation between procoagulant activity of red blood cells from different phenotypes and in vivo blood coagulation activation

British Journal of Haematology

Volumn 99, Issue 2, 1997, Pages 268-272

  Helley, Dominique ^a,b   Girot, Robert ^c   Guillin, Marie Claude ^a,b   Bezeaud, Annie ^a,b  

^a BEAUJON HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL TENON   (France)

Author keywords

Phospholipids; Procoagulant; Prothrombin; Red blood cells; Sickle cell disease

Indexed keywords

ANTITHROMBIN; PHOSPHOLIPID; PROCOAGULANT; PROTHROMBIN; THROMBIN;

ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL FEATURE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

EID: 0030694226     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.4173226.x     Document Type: Article

References (26)

1. Bajaj, S.P., Rapaport, S.I. & Prodanos, C. (1981) A simplified procedure for purification of human prothrombin, factor IX and factor X. Preparative Biochemistry, 2, 397-412.
2. Bezeaud, A., Drouet, L. Soria, C. & Guillin, M.C. (1984) Prothrombin Salakta: abnormal prothrombin characterized by a defect in the active site of thrombin. Thrombosis Research, 34, 507-518.
3. Blumenfeld, N., Zachowski, A., Galacteros, E, Beuzard, Y. & Devaux, P (1991) Transmembrane mobility of phospholipid in sickle erythrocytes: effect of deoxygenation on diffusion and asymmetry. Blood, 77, 849-854.
4. Bridges, K.R., Barabino, G.D., Brugnara, C., Cho, M.R., Christoph, G.W., Dover, G., Ewenstein, B.M., Golan, D.H., Guttmann, C.R.G., Hofrichter, J., Mulkern, R.V., Zhang, B. & Eaton, W.A. (1996) A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy. Blood, 88, 4701-4710.
5. Chiu, D, Lubin, B., Roelofsen, B. & Van Deenen, L.L.M. (1981) Sickled erythrocytes accelerate clotting in vitro: an effect of abnormal membrane lipid asymmetry. Blood, 58, 398-401.
6. Connor, J., Bucana, C., Fidler, I.J. & Schroit, A.J. (1989) Differentiation-dependent expression of phosphatidylserine in mammalian plasma membranes: quantitative assessment of outer-leaflet lipid by prothrombinase complex formation. Proceedings of the National Academy of Sciences of the United States of America, 86, 3184-3188.
7. Francis, R.B. (1989) Elevated fibrin D-Dimer fragment in sickle cell anaemia: evidence for activation of coagulation during the steady state as well as in painful crisis. Haemostasis, 29, 105-111.
8. Francis, R.B. (1991) Platelets, coagulation and fibrinolysis in sickle cell disease: their possible role in vascular occlusion. Blood Coagulation and Fibrinolysis, 2, 341-353.
9. 2 (Stuart factor) isolation and characterization. Biochemistry, 11, 4882-4891.
10. Green, D. & Scott, J.P. (1986) Is sickle cell crisis a thrombotic event? American Journal of Hematology, 23, 317-321.
11. Hagger, D., Wolff, S., Owen, J. & Samson, D. (1995) Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy Blacks controls. Blood Coagulation and fibrinolysis, 6, 93-99.
12. Hebbel, R.P. (1991) Beyond haemoglobin polymerization: the red blood cell membrane and sickle cell disease. Blood, 77, 214-237.
13. Helley, D., Eldor, A., Girot, R., Ducrocq, R., Guillin, M.C. & Bezeaud, A. (1996) Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and β-thalassemia. Thrombosis and Haemostasia, 76, 522-327.
14. Kurantsin-Mills, J., Ofosu, F.A., Safa, T.K., Siegel, R.S. & Lessin, L.S. (1992) Plasma factor VII and thrombin-antithrombin III levels indicate tissue factor activity in sickle cell patients. British Journal of Haematology, 81, 539-544.
15. Kuypers, FA., Lewis, R.A., Hua, M., Schott, M.A., Discher, D., Ernst, J.D. & Lubin, B.H. (1996) Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood, 87, 1179-1187.
16. Lubin, B., Chiu, D., Bastacky, J., Roelofsen, H. & Van Deenen, L.L.M. (1981) Abnormalities in membrane phospholipid organization in sickled erythrocytes. Journal of Clinical Investigation, 67, 1643-1649.
17. Middlekoop, E., Lubin, B., Bevers, E.M., Op Den Kamp, J.A.F., Comfurius, P., Chiu, D.T.Y., Zwaal, R.FA. & Van Deenen, L.L.M. (1988) Studies on sickled erythrocytes provide evidence that the asymmetric distribution of phosphatidylserine in the red cell membrane is maintained by both ATP-dependent translocation and interaction with membrane skeletal proteins. Biochimica et Biophysica Acta, 937, 281-288.
18. Nesheim, M.E., Taswell, J.R. & Mann, K.G. (1979) The contribution of bovine factor V and factor Va to the activity of prothrombinase. Journal of Biological Chemistry, 254, 10952-10962.
19. Nziri, B., Gritli, N., Bayoudh, F., Messaoud, T., Fattoum, S. & Machghoul, S. (1996) Abnormalities of coagulation and librinolysis in homozygous sickle cell disease. Hematology and Cell Therapy, 38, 279-284.
20. Peters, M., Plaat, B.E.C., Ten Cate, H., Wolters, H.J., Weening, R.S. & Brandjes, D.P.M. (1994) Enhanced thrombin generation in children with sickle cell disease. Thrombosis and Haemostasis, 71, 169-172.
21. Rosing, J., Tans, G., Govers-Riemslag, J.W.P., Zwall, R.F.A. & Hemker, H.C. (1980) The role of phospholipids and factor Va in the prothrombinase complex. Journal of Biological Chemistry, 255, 274-283.
22. Schroit, A.J. & Zwaal, R.F.A. (1991) Transbilayer movement of phospholipids in red cell and platelet membranes. Biochimica et Biophysica Acta, 1071, 313-329.
23. Tait, J.F. & Gibson, D. (1994) Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding. Journal of Laboratory and Clinical Medicine, 123, 741-748.
24. Van Rijn, J.L.M.L., Govers-Riemslag, J.W.P., Zwaal, R.F.A. & Rosing, J. (1984) Kinetic studies of prothrombin activation: effect of factor Va and phospholipids on the formation of the enzyme substrate complex. Biochemistry, 23, 4557-4564.
25. Wood, B.L., Gibson, D.F. & Tait, J.F. (1996) Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood, 88, 1873-1880.
26. Wollers, H.J., Ten Cate, H., Thomas, L.L.M., Brandjes, D.P.M., Van der Ende, A., Van der Heiden, Y. & Statius van Eps, L.W. (1995) Low-intensity oral anticoagulation in sickle-cell disease reverses the prethrombotic state: promises for treatment? British Journal of Haematology, 90, 715-717.